BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30327774)

  • 21. Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer.
    Guo J; Yu X; Gu J; Lin Z; Zhao G; Xu F; Lu C; Ge D
    Tumour Biol; 2016 May; 37(5):6371-8. PubMed ID: 26631033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rap1A promotes esophageal squamous cell carcinoma metastasis through the AKT signaling pathway.
    Li Q; Xu A; Chu Y; Chen T; Li H; Yao L; Zhou P; Xu M
    Oncol Rep; 2019 Nov; 42(5):1815-1824. PubMed ID: 31545475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of PLOD2 in esophageal squamous cell carcinoma and its correlation with invasion and metastasis].
    Di WY; Kang XH; Zhang JH; Wang Y; Kou WZ; Su W
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):102-107. PubMed ID: 30695860
    [No Abstract]   [Full Text] [Related]  

  • 24. NKILA inhibits NF-κB signaling and suppresses tumor metastasis.
    Ke S; Li RC; Meng FK; Fang MH
    Aging (Albany NY); 2018 Jan; 10(1):56-71. PubMed ID: 29348395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depletion of LAMP3 enhances PKA-mediated VASP phosphorylation to suppress invasion and metastasis in esophageal squamous cell carcinoma.
    Huang F; Ma G; Zhou X; Zhu X; Yu X; Ding F; Cao X; Liu Z
    Cancer Lett; 2020 Jun; 479():100-111. PubMed ID: 32200035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.
    Zhan Y; Li R; Feng C; Li X; Huang S; Wang L; Liu Z; Jiang J; Han Y
    Biomed Pharmacother; 2020 Jan; 121():109602. PubMed ID: 31707349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
    Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM
    Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumour effects of a macrolide analog F806 in oesophageal squamous cell carcinoma cells by targeting and promoting GLUT1 autolysosomal degradation.
    Li X; Li L; Wu X; Wen B; Lin W; Cao Y; Xie L; Zhang H; Dong G; Li E; Xu L; Cheng Y
    FEBS J; 2022 Nov; 289(21):6782-6798. PubMed ID: 35653269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma.
    Tang H; Jiang L; Zhu C; Liu R; Wu Y; Yan Q; Liu M; Jia Y; Chen J; Qin Y; Lee VH; Luo S; Wang Q; Guan XY
    Oncogene; 2019 Apr; 38(17):3119-3133. PubMed ID: 30622339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
    Qiu F; Liu L; Lin Y; Yang Z; Qiu F
    Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA‑675‑3p promotes esophageal squamous cell cancer cell migration and invasion.
    Xiao Q; Chen T; Wu Y; Wu W; Xu Y; Gong Z; Chen S
    Mol Med Rep; 2018 Oct; 18(4):3631-3640. PubMed ID: 30106155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-375 suppresses invasion and metastasis by direct targeting of SHOX2 in esophageal squamous cell carcinoma.
    Yi J; Jin L; Chen J; Feng B; He Z; Chen L; Song H
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):159-169. PubMed ID: 28069583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6.
    Hou S; Hao X; Li J; Weng S; Wang J; Zhao T; Li W; Hu X; Deng B; Gu J; Hang Q
    Cell Death Dis; 2022 Jul; 13(7):609. PubMed ID: 35835740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
    Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
    Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-92b represses invasion-metastasis cascade of esophageal squamous cell carcinoma.
    Ma G; Jing C; Li L; Huang F; Ding F; Wang B; Lin D; Luo A; Liu Z
    Oncotarget; 2016 Apr; 7(15):20209-22. PubMed ID: 26934001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.
    Zhan XH; Jiao JW; Zhang HF; Xu XE; He JZ; Li RL; Zou HY; Wu ZY; Wang SH; Wu JY; Liao LD; Wang JJ; Cheng YW; Zhang K; Neufeld G; Xu LY; Li EM
    Cancer Res; 2019 Oct; 79(19):4951-4964. PubMed ID: 31409639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.
    Chai Y; Li Q; Zhao H; Zhang Z; Yu X; Pang L; Liu Z; Zhao J; Wang L; Li F
    Cancer Med; 2019 Nov; 8(16):7055-7064. PubMed ID: 31560173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RasGRP3, a Ras guanyl releasing protein 3 that contributes to malignant proliferation and aggressiveness in human esophageal squamous cell carcinoma.
    Zhang Z; Ma M; Hu R; Xu B; Zong L; Wei H; Meng Y
    Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):720-728. PubMed ID: 29461644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma.
    Niu F; Liu Y; Jing Z; Han G; Sun L; Yan L; Zhou L; Wu Y; Xu Y; Hu L; Zhao X
    Cancer Lett; 2018 Apr; 420():60-71. PubMed ID: 29408653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.